Claudin 18.2 Expression and Outcomes of First-Line Chemoimmunotherapy in HER2-Negative Gastric or Gastroesophageal Junction Cancer: A Single-Center Retrospective Study.
Simple Summary: Gastric cancer remains difficult to treat, especially when it has spread. A protein called Claudin18.2 is found on many stomach cancer cells and is being studied as a possible target for new drugs. This study looked at 189 patients with HER2-negative gastric cancer to understand whet...
| Publicado en: | Current Oncology Vol. 33; no. 8; pp. 460 - 476 |
|---|---|
| Autores principales: | , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Aug2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |